Literature DB >> 33011533

TCF3-activated FAM201A enhances cell proliferation and invasion via miR-186-5p/TNKS1BP1 axis in triple-negative breast cancer.

Hongyao Jia1, Di Wu2, Zhiru Zhang3, Sijie Li4.   

Abstract

Increasing evidence shows that long non-coding RNAs (lncRNAs) are closely associated with the development of cancers, including triple-negative breast cancer (TNBC). LncRNA FAM201A has been identified as a key regulator in some cancers. However, its role has not been explored in TNBC. In this work, we investigated the biological role and regulatory mechanism of FAM201A in TNBC. The expression pattern of FAM201A was determined by RT-qPCR analysis. The biological effect of FAM201A on cellular process of TNBC was tested using colony formation, EdU, caspase-3 activity detection, flow cytometry, wound healing, and Transwell assays. ChIP and luciferase reporter assays were performed to verify the interaction between transcription factor 3 (TCF3) and FAM201A. The interaction among FAM201A, microRNA-186-5p (miR-186-5p), and tankyrase 1 binding protein 1 (TNKS1BP1) was evaluated by luciferase reporter and RIP assays. The results showed that FAM201A expression was significantly upregulated in TNBC tissues and cells. Functionally, FAM201A knockdown inhibited TNBC cell proliferation, migration and invasion, and accelerated cell apoptosis. In mechanism, it was confirmed that FAM201A was transcriptionally activated by TCF3 and served as a sponge for miR-186-5p to upregulate TNKS1BP1 expression in TNBC cells. Collectively, our study revealed that TCF3-activated FAM201A promoted aggressive phenotypes of TNBC cells by upregulating TNKS1BP1 expression.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  FAM201A; TCF3; TNBC; TNKS1BP1; miR-186-5p

Year:  2020        PMID: 33011533     DOI: 10.1016/j.bioorg.2020.104301

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  6 in total

1.  TCF3 Induces DNMT1 Expression to Regulate Wnt Signaling Pathway in Glioma.

Authors:  Wei Zeng; Haixiao Jiang; Ying Wang; Cunzu Wang; Bo Yu
Journal:  Neurotox Res       Date:  2022-04-21       Impact factor: 3.911

2.  Precision Targeting of Endogenous Epidermal Growth Factor Receptor (EGFR) by Structurally Aligned Dual-Modifier Labeling.

Authors:  Ivan de Jesus Salazar-Estrada; Karthik Shantharam Kamath; Fei Liu
Journal:  ACS Pharmacol Transl Sci       Date:  2022-09-19

3.  Transcriptional factor 3 binds to sirtuin 1 to activate the Wnt/β-catenin signaling in cervical cancer.

Authors:  Xiao Yu; Zhaoshuo Li; Ruihua Bai; Fuxiang Tang
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

4.  Positive feedback loop of lncRNA FAM201A/miR‑146a‑5p/POU2F1 regulates IL‑1β‑induced chondrocyte injury in vitro.

Authors:  Kaifeng Gan; Wei Wu; Jie Li; Dingli Xu; Yunpeng Liu; Mingguang Bi; Liangjie Lu; Jin Li
Journal:  Mol Med Rep       Date:  2021-11-19       Impact factor: 2.952

5.  Bombyx mori miR-2845 represses the expression of fibroin light chain gene both in vitro and in vivo.

Authors:  JingYi Huang; YanHua Chen; Juan Zhu; MeiXian Wang; ShunMing Tang; YongZhu Yi; XingJia Shen
Journal:  PLoS One       Date:  2021-12-16       Impact factor: 3.240

6.  FAM201A Promotes Cervical Cancer Progression and Metastasis through miR-1271-5p/Flotillin-1 Axis Targeting-Induced Wnt/β-Catenin Pathway.

Authors:  Yuehong Wang; Zhilian Wang; Keyan Cheng; Qirong Hao
Journal:  J Oncol       Date:  2022-10-03       Impact factor: 4.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.